다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

IRWD Ironwood Pharmaceuticals Inc

4.51

0.18 (4.16%)

시간외 거래

최종 업데이트: 14:00:11

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Shares sold to cover taxes from the vesting of stock awards granted by the Issuer.

Date of Notice

02/09/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Michael Shetzline

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Ironwood Pharmaceuticals (NASDAQ:IRWD)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025

Ironwood Pharmaceuticals 차트를 더 보려면 여기를 클릭.

Ironwood Pharmaceuticals (NASDAQ:IRWD)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025

Ironwood Pharmaceuticals 차트를 더 보려면 여기를 클릭.

Ironwood Pharmaceuticals Inc News

Form 144 - Report of proposed sale of securities
0년 28월 12일, 2024 (1 주 전) • Edgar (US Regulatory)

Form 8-K - Current report
0년 6월 12일, 2024 (1 월 전) • Edgar (US Regulatory)

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
0년 27월 11일, 2024 (1 월 전) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
0년 21월 11일, 2024 (2 월 전) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
0년 21월 11일, 2024 (2 월 전) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
0년 16월 11일, 2024 (2 월 전) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
0년 16월 11일, 2024 (2 월 전) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
0년 15월 11일, 2024 (2 월 전) • Edgar (US Regulatory)

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
0년 14월 11일, 2024 (2 월 전) • Business Wire

Form 8-K - Current report
0년 13월 11일, 2024 (2 월 전) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
0년 8월 11일, 2024 (2 월 전) • Edgar (US Regulatory)

Form 8-K - Current report
0년 7월 11일, 2024 (2 월 전) • Edgar (US Regulatory)

More Ironwood Pharmaceuticals Inc News Articles

Bank of America

American Express

Deutsche Telekom (QX)

Health Care Select Sector

BNP Paribas (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관